BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carroll MW, Kuenzig ME, Mack DR, Otley AR, Griffiths AM, Kaplan GG, Bernstein CN, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Benchimol EI. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD. J Can Assoc Gastroenterol 2019;2:S49-67. [PMID: 31294385 DOI: 10.1093/jcag/gwy056] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Chen X, Gao Y, Xie J, Hua H, Pan C, Huang J, Jing M, Chen X, Xu C, Gao Y, Li P. Identification of FCN1 as a novel macrophage infiltration-associated biomarker for diagnosis of pediatric inflammatory bowel diseases. J Transl Med 2023;21:203. [PMID: 36932401 DOI: 10.1186/s12967-023-04038-1] [Reference Citation Analysis]
2 Chen L, Wang D, Zhou Y. The Illness Experiences of Chinese Adolescent Patients Living with Crohn Disease: A Descriptive Qualitative Study. Gastroenterol Nurs 2023. [PMID: 36882914 DOI: 10.1097/SGA.0000000000000723] [Reference Citation Analysis]
3 Bay M C, Núñez F P, Quera R, Yarur AJ. Current perspectives on pediatric inflammatory bowel disease focusing on transitional care management. What should we consider? Gastroenterol Hepatol 2023;46:139-47. [PMID: 36243253 DOI: 10.1016/j.gastrohep.2022.10.003] [Reference Citation Analysis]
4 Salguero MV, Deplewski D, Gokhale R, Wroblewski K, Sentongo T, Jan A, Kirschner BS. Growth After Menarche in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2023;76:183-90. [PMID: 36705699 DOI: 10.1097/MPG.0000000000003667] [Reference Citation Analysis]
5 Bay M C, Núñez F P, Quera R, Yarur AJ. Current perspectives on pediatric inflammatory bowel disease focusing on transitional care management. What should we consider? Gastroenterología y Hepatología (English Edition) 2023;46:139-147. [DOI: 10.1016/j.gastre.2022.10.002] [Reference Citation Analysis]
6 Jeong J, Walters TD, Huynh HQ, Lawrence S, Mack DR, Deslandres C, Otley A, El-Matary W, Sherlock M, Griffiths AM, Wine E, Jacobson K, Church P, Carroll MW, Benchimol EI, Brill H, Critch J, Bax K, Jantchou P, Rashid M, Kaplan GG, Seow CH, Novak K, deBruyn JC; Canadian Children IBD Network. Inflammatory Bowel Disease Among Canadian Children: Comparison Between Children of Non-European Descent and Children of European Descent. Inflamm Bowel Dis 2023:izac276. [PMID: 36688453 DOI: 10.1093/ibd/izac276] [Reference Citation Analysis]
7 Chen Z, Nong Y, Wang Q, Feng L, He Y, Guo B, Qin Y, Zhong X, Qin J, Wei J, Dong M, Pan S, Su Z. Preventive effect of tilapia skin collagen hydrolysates on ulcerative colitis mice based on metabonomic and 16 S rRNA gene sequencing. J Sci Food Agric 2023. [PMID: 36645331 DOI: 10.1002/jsfa.12457] [Reference Citation Analysis]
8 Brown SC, Whelan K, Frampton C, Wall CL, Gearry RB, Day AS. Food-Related Quality of Life in Children and Adolescents With Crohn's Disease. Inflamm Bowel Dis 2022;28:1838-43. [PMID: 35166341 DOI: 10.1093/ibd/izac010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
9 Vaghari-tabari M, Alemi F, Zokaei M, Moein S, Qujeq D, Yousefi B, Farzami P, Hosseininasab SS. Polyphenols and inflammatory bowel disease: Natural products with therapeutic effects? Critical Reviews in Food Science and Nutrition 2022. [DOI: 10.1080/10408398.2022.2139222] [Reference Citation Analysis]
10 Rishworth A, Cao T, Niraula A, Wilson K. Health Care Use and Barriers to Care for Chronic Inflammatory Diseases (CID) among First and Second Generation South Asian Immigrant Children and Parents in Ontario Canada. Int J Environ Res Public Health 2022;19. [PMID: 36361486 DOI: 10.3390/ijerph192114608] [Reference Citation Analysis]
11 Zeng Y, Peng J, Gao X, Tian D, Zhan W, Liu J, Hu X, Huang S, Tian S, Qiu L, Liang A, Wang F, Dong R, Guang B, Yang T. A novel gut-restricted RIPK1 inhibitor, SZ-15, ameliorates DSS-induced ulcerative colitis. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.175381] [Reference Citation Analysis]
12 Bihari A, Olayinka L, Kroeker KI. Outcomes in Patients with Inflammatory Bowel Disease Transitioning from Pediatric to Adult Care: A Scoping Review. J Pediatr Gastroenterol Nutr 2022;75:423-30. [PMID: 35920854 DOI: 10.1097/MPG.0000000000003581] [Reference Citation Analysis]
13 Kern I, Schoffer O, Richter T, Kiess W, Flemming G, Winkler U, Quietzsch J, Wenzel O, Zurek M, Manuwald U, Hegewald J, Li S, Weidner J, de Laffolie J, Zimmer K, Kugler J, Laass MW, Rothe U. Current and projected incidence trends of pediatric-onset inflammatory bowel disease in Germany based on the Saxon Pediatric IBD Registry 2000–2014 –a 15-year evaluation of trends. PLoS ONE 2022;17:e0274117. [DOI: 10.1371/journal.pone.0274117] [Reference Citation Analysis]
14 Suarez RG, Osornio-Vargas AR, Wine E. Ambient Air Pollution and Pediatric Inflammatory Bowel Diseases: An Updated Scoping Review. Dig Dis Sci 2022;67:4342-54. [PMID: 35751831 DOI: 10.1007/s10620-022-07597-3] [Reference Citation Analysis]
15 Alhadab AA, AlMahamed SN, Hassan IE, Hammo AH. The impact of inflammatory bowel diseases on the quality of life of Saudi pediatric patients: A cross-sectional study. Saudi J Gastroenterol 2022;28:448-55. [PMID: 35946259 DOI: 10.4103/sjg.sjg_162_22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Hudson AS, Almeida P, Huynh HQ. Dual Biologic Therapy in a Patient With Niemann-Pick Type C and Crohn Disease: A Case Report and Literature Review. JPGN Reports 2022;3:e225. [DOI: 10.1097/pg9.0000000000000225] [Reference Citation Analysis]
17 Seow CH, Coward S, Kroeker KI, Stach J, Devitt KS, Targownik LE, Nguyen GC, Ma C, deBruyn JC, Carroll MW, Peerani F, Baumgart DC, Ryan DJ, Veldhuyzen van Zanten S, Benchimol EI, Kaplan GG, Panaccione R. Declining Corticosteroid Use for Inflammatory Bowel Disease Across Alberta: A Population-Based Cohort Study. Journal of the Canadian Association of Gastroenterology 2022. [DOI: 10.1093/jcag/gwac021] [Reference Citation Analysis]
18 Cesa KT, Cunningham CA, Noll RB, Kim SC. Parental Distress in Pediatric Inflammatory Bowel Diseases: Associations With Time From Diagnosis, Disease Activity, and Demographic Factors. Crohns Colitis 360 2022;4:otac019. [PMID: 35783219 DOI: 10.1093/crocol/otac019] [Reference Citation Analysis]
19 Peng L, Hu S, Yu Q, Chen Y. Challenging the Surge of Inflammatory Bowel Disease: The Role of the China Crohn's and Colitis Foundation in the Healthcare Landscape of Inflammatory Bowel Disease. Inflamm Bowel Dis 2022;28:S9-S15. [PMID: 34984463 DOI: 10.1093/ibd/izab344] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Przerwa F, Kukowka A, Niezgoda J, Kotrych K, Uzar I. Use of polyunsaturated fatty acids in prevention and treatment of gastrointestinal diseases, obesity and cancer. Herba Polonica 2022;68:76-85. [DOI: 10.2478/hepo-2022-0009] [Reference Citation Analysis]
21 Rishworth AC, Niraula A, Cao T, Carrillo Lay J, Ferrari J, Zaman S, Wilson K. Knowledge, risk perceptions and practices surrounding chronic inflammatory diseases among first and second generation South Asian immigrants parents and children. IJMHSC 2022;18:139-152. [DOI: 10.1108/ijmhsc-01-2022-0003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Usoltseva OV, Surkov AN, Movsisyan GB, Potapov AS, Kulebina EA, Kulikov КA, Chernikov VV. Correlation of Inflammatory Bowel Diseases with Liver Involvement Severity in Autoimmune Hepatobiliary Pathology: Cross-Sectional Study. Vopr sovr pediatr 2022;21:105-112. [DOI: 10.15690/pf.v19i2.2407] [Reference Citation Analysis]
23 Bollegala N, Barwick M, Fu N, Griffiths AM, Keefer L, Kohut SA, Kroeker KI, Lawrence S, Lee K, Mack DR, Walters TD, de Guzman J, Tersigni C, Miatello A, Benchimol EI. Multimodal intervention to improve the transition of patients with inflammatory bowel disease from pediatric to adult care: protocol for a randomized controlled trial. BMC Gastroenterol 2022;22:251. [PMID: 35585484 DOI: 10.1186/s12876-022-02307-9] [Reference Citation Analysis]
24 Alvisi P, Labriola F, Scarallo L, Gandullia P, Knafelz D, Bramuzzo M, Zuin G, Pastore MR, Illiceto MT, Miele E, Graziano F, Romano C, Bartoletti D, Oliva S, Arrigo S, Bracci F, Renzo S, Agrusti A, Aloi M, Lionetti P; SIGENP IBD Working Group. Epidemiological trends of pediatric IBD in Italy: A 10-year analysis of the Italian society of pediatric gastroenterology, hepatology and nutrition registry. Dig Liver Dis 2022;54:469-76. [PMID: 35125313 DOI: 10.1016/j.dld.2021.12.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Fu N, Bollegala N, Jacobson K, Kroeker KI, Frost K, Afif W, El-matary W, Fowler SA, Griffiths AM, Huynh HQ, Jantchou P, Karimuddin A, Nguyen GC, Otley AR, Pears C, Seow CH, Toulany A, Tersigni C, Tignanelli J, Marshall JK, Boctor M, Hansen T, Pattni C, Wong A, Benchimol EI. Canadian Consensus Statements on the Transition of Adolescents and Young Adults with Inflammatory Bowel Disease from Pediatric to Adult Care: A Collaborative Initiative Between the Canadian IBD Transition Network and Crohn’s and Colitis Canada. Journal of the Canadian Association of Gastroenterology 2022. [DOI: 10.1093/jcag/gwab050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Pachter-alt A, Soskolne V. It’s All in the Head: Illness Perception is the Major Correlate of Quality of Life Among Adolescents with Inflammatory Bowel Disease. Child Adolesc Soc Work J. [DOI: 10.1007/s10560-022-00823-x] [Reference Citation Analysis]
27 Jongsma MME, Aardoom MA, Cozijnsen MA, van Pieterson M, de Meij T, Groeneweg M, Norbruis OF, Wolters VM, van Wering HM, Hojsak I, Kolho KL, Hummel T, Stapelbroek J, van der Feen C, van Rheenen PF, van Wijk MP, Teklenburg-Roord STA, Schreurs MWJ, Rizopoulos D, Doukas M, Escher JC, Samsom JN, de Ridder L. First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial. Gut 2022;71:34-42. [PMID: 33384335 DOI: 10.1136/gutjnl-2020-322339] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 28.0] [Reference Citation Analysis]
28 Raymond M, Marsicovetere P, DeShaney K. Diagnosing and managing acute abdominal pain in children. JAAPA 2022;35:16-20. [PMID: 34908557 DOI: 10.1097/01.JAA.0000803624.08871.5f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Aloi M, Cucchiara S. Crohn’s Disease. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition 2022. [DOI: 10.1007/978-3-030-80068-0_28] [Reference Citation Analysis]
30 Kapfhammer H. Gastrointestinale Erkrankungen. Depression, Angst, traumatischer Stress und internistische Erkrankungen 2022. [DOI: 10.1007/978-3-662-65873-4_6] [Reference Citation Analysis]
31 Pratt M, Forbes JD, Knox NC, Bernstein CN, Van Domselaar G. Microbiome-Mediated Immune Signaling in Inflammatory Bowel Disease and Colorectal Cancer: Support From Meta-omics Data. Front Cell Dev Biol 2021;9:716604. [PMID: 34869308 DOI: 10.3389/fcell.2021.716604] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Kaplan GG, Windsor JW, Crain J, Barrett L, Bernstein CN, Bitton A, Chauhan U, Coward S, Fowler S, Ghia JE, Gibson DL, Griffiths AM, Jones JL, Khanna R, Kuenzig ME, Lakatos PL, Lee K, Mack DR, Marshall JK, Mawani M, Murthy SK, Panaccione R, Seow CH, Targownik LE, Zelinsky S, Benchimol EI. Crohn's and Colitis Canada's 2021 Impact of COVID-19 & Inflammatory Bowel Disease in Canada: A Knowledge Translation Strategy. J Can Assoc Gastroenterol 2021;4:S10-9. [PMID: 34755034 DOI: 10.1093/jcag/gwab028] [Reference Citation Analysis]
33 Qu W, Liu L, Miao L. Exposure to antibiotics during pregnancy alters offspring outcomes. Expert Opin Drug Metab Toxicol 2021;17:1165-74. [PMID: 34435921 DOI: 10.1080/17425255.2021.1974000] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
34 Brenner EJ, Long MD, Mann CM, Lin L, Chen W, Reyes C, Bahnson KM, Reeve BB, Kappelman MD. Anxiety and Depressive Symptoms Are Not Associated With Future Pediatric Crohn's Disease Activity. Inflamm Bowel Dis 2022;28:728-33. [PMID: 34245258 DOI: 10.1093/ibd/izab162] [Reference Citation Analysis]
35 Dheri AK, Kuenzig ME, Mack DR, Murthy SK, Kaplan GG, Donelle J, Smith G, Benchimol EI. Shifting Health Care Use from Hospitalisations and Surgeries to Outpatient Visits in Children with Inflammatory Bowel Disease: A Population-based Cohort Study from Ontario, Canada. J Crohns Colitis 2021;15:1991-2000. [PMID: 34019625 DOI: 10.1093/ecco-jcc/jjab095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Bulavenko O, Konkov D, Kuzminova N, Lobastova T, Oleksienko I. Optimization of antenatal monitoring approaches of women with chronic inflammatory bowel diseases. RE 2021. [DOI: 10.18370/2309-4117.2021.57.84-92] [Reference Citation Analysis]
37 Castillo G, Mack DR, Lalu MM, Singleton R, Fergusson DA, Stintzi A, Harrison M, Presseau J. Factors contributing to fidelity in a pilot trial of individualized resistant starches for pediatric inflammatory bowel disease: a fidelity study protocol. Pilot Feasibility Stud 2021;7:75. [PMID: 33741062 DOI: 10.1186/s40814-021-00815-1] [Reference Citation Analysis]
38 Mosli MH, Saadah OI. Metabolic bone disease in children and adolescent patients with ulcerative colitis. J Pediatr (Rio J) 2021;97:242-7. [PMID: 32335076 DOI: 10.1016/j.jped.2020.03.003] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Iida C, Tatsumi A, Fujino H, Anzai K, Sumimoto S. Infantile Inflammatory Bowel Disease in a Three-Month-Old-Boy. Cureus 2021;13:e12743. [PMID: 33643722 DOI: 10.7759/cureus.12743] [Reference Citation Analysis]
40 Kern I, Schoffer O, Kiess W, Henker J, Laaß MW, Winkler U, Quietzsch J, Wenzel O, Zurek M, Büttner K, Fischer P, de Laffolie J, Manuwald U, Stange T, Zenker R, Weidner J, Zimmer KP, Kunath H, Kugler J, Richter T, Rothe U. Incidence trends of pediatric onset inflammatory bowel disease in the years 2000-2009 in Saxony, Germany-first results of the Saxon Pediatric IBD Registry. PLoS One 2021;16:e0243774. [PMID: 33395450 DOI: 10.1371/journal.pone.0243774] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
41 Seth A, Yen YM, Tourn D, Smit K, Carsen S. A Unique and Characteristic Cam FAI Morphology in Young Patients with Comorbid Inflammatory Conditions. J Bone Joint Surg Am 2020;102:15-21. [PMID: 32453107 DOI: 10.2106/JBJS.20.00080] [Reference Citation Analysis]
42 Laube R, Yau Y, Selinger CP, Seow CH, Thomas A, Wei Chuah S, Hilmi I, Mao R, Ong D, Ng SC, Chen Wei S, Banerjee R, Ahuja V, Alharbi O, Leong RW. Knowledge and Attitudes Towards Pregnancy in Females with Inflammatory Bowel Disease: An International, Multi-centre Study. J Crohns Colitis 2020;14:1248-55. [PMID: 32191292 DOI: 10.1093/ecco-jcc/jjaa047] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
43 Mouratidou N, Malmborg P, Olén O. Letter: is unrealised adult height resulting from paediatric Crohn's disease associated with a potential reduction in lifetime earnings? Authors' reply. Aliment Pharmacol Ther 2020;52:560-1. [PMID: 32656832 DOI: 10.1111/apt.15899] [Reference Citation Analysis]
44 Aardoom MA, Kemos P, Tindemans I, Aloi M, Koletzko S, Levine A, Turner D, Veereman G, Neyt M, Russell RK, Walters TD, Ruemmele FM, Samsom JN, Croft NM, de Ridder L; PIBD-SETQuality consortium and PIBD-NET. International prospective observational study investigating the disease course and heterogeneity of paediatric-onset inflammatory bowel disease: the protocol of the PIBD-SETQuality inception cohort study. BMJ Open 2020;10:e035538. [PMID: 32611739 DOI: 10.1136/bmjopen-2019-035538] [Reference Citation Analysis]
45 Walsh CM, Fishman DS, Lerner DG; NASPGHAN Endoscopy and Procedures Committee. Pediatric Endoscopy in the Era of Coronavirus Disease 2019: A North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper. J Pediatr Gastroenterol Nutr 2020;70:741-50. [PMID: 32443022 DOI: 10.1097/MPG.0000000000002750] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
46 Filimoniuk A, Daniluk U, Samczuk P, Wasilewska N, Jakimiec P, Kucharska M, Lebensztejn DM, Ciborowski M. Metabolomic profiling in children with inflammatory bowel disease. Adv Med Sci 2020;65:65-70. [PMID: 31901795 DOI: 10.1016/j.advms.2019.12.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
47 Kaplan GG, Ma C, Seow CH, Kroeker KI, Panaccione R. The Argument Against a Biosimilar Switch Policy for Infliximab in Patients with Inflammatory Bowel Disease Living in Alberta. J Can Assoc Gastroenterol 2020;3:234-42. [PMID: 32905124 DOI: 10.1093/jcag/gwz044] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
48 El-Matary W, Kuenzig ME, Singh H, Okoli G, Moghareh M, Kumar H, Lê ML, Benchimol EI. Disease-Associated Costs in Children With Inflammatory Bowel Disease: A Systematic Review. Inflamm Bowel Dis 2020;26:206-15. [PMID: 31211827 DOI: 10.1093/ibd/izz120] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
49 Chandrakumar A, Loeppky R, Deneau M, El-Matary W. Inflammatory Bowel Disease in Children with Elevated Serum Gamma Glutamyltransferase Levels. J Pediatr 2019;215:144-151.e3. [PMID: 31500861 DOI: 10.1016/j.jpeds.2019.07.065] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
50 Carman N, Mack DR, Benchimol EI. Anticipatory care of children and adolescents with inflammatory bowel disease: a primer for primary care providers. Curr Opin Pediatr 2019;31:654-60. [PMID: 31205126 DOI: 10.1097/MOP.0000000000000795] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
51 Windsor JW, Kaplan GG. Evolving Epidemiology of IBD. Curr Gastroenterol Rep. 2019;21:40. [PMID: 31338613 DOI: 10.1007/s11894-019-0705-6] [Cited by in Crossref: 108] [Cited by in F6Publishing: 84] [Article Influence: 27.0] [Reference Citation Analysis]